Eric Lu is responsible for Marketing, Intelligence and BD Europe at WuXi XDC, a dedicated CRO and CDMO for ADC and bioconjugate. WuXi XDC provides single-source discovery, development and manufacturing services for antibody drug conjugates (ADCs) and other novel bioconjugates. These comprehensive, integrated CRDMO services include the key intermediates, such as the chemical payload-linkers and the biologics (e.g., monoclonal, bispecific and multispecific antibodies or other recombinant proteins), in addition to the bioconjugate drug substance and drug product. This one-stop approach and the fact all services are within an hours drive allows us to provide an unprecedented streamlined platform that cuts in half the time it takes to develop and manufacture these complex modalities.